1Department of Clinical Research, Biometrics, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
New clinical trials increasingly compare active treatments, not placebos. This requires demonstrating equivalence between experimental drugs like moclobemide and standard therapies, posing complex statistical challenges.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: